FDA Approved: STEQEYMA — Original Application (CELLTRION USA, Inc.)

View source ↗

Summary

FDA approved STEQEYMA (ustekinumab-stba) from Celltrion USA as a biosimilar to ustekinumab under an original biologics license application. It is approved for p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• STEQEYMA (USTEKINUMAB-STBA)

Snippet

ORIG AP for STEQEYMA (USTEKINUMAB-STBA)